康诺亚第 2 款 ADC 首次启动临床

Insight数据库
05 Jun

近日,康诺亚在药物临床试验登记与信息公示平台官网上登记了一项CDH17 ADC药物 CM518D1 治疗晚期实体瘤的I/II期临床研究。据公开资料显示,这是该药首次启动临床。来自:药物临床试验登记与信息公示平台官网这是一项多中心、开放性、 I/II 期临床研究,旨在评价 CM518D1 治疗晚期实体瘤患者的安全性、耐受性和初步疗效。研究的主要终点是安全性和耐受性(不良事件、实验室检查、剂量限制性...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10